CI-601, a butyrophenone derivative, in the treatment of chronically withdrawn schizophrenic patients.
D000328:Adult; D002090:Butyrophenones / Q000627:therapeutic use; D002908:Chronic Disease; D002986:Clinical Trials as Topic; D005260:Female; D006220:Haloperidol / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D012559:Schizophrenia / Q000188:drug therapy*
D002090:Butyrophenones; D006220:Haloperidol